Nguyen, P L
Martin, N E
Choeurng, V
Palmer-Aronsten, B
Kolisnik, T
Beard, C J
Orio, P F
Nezolosky, M D
Chen, Y-W
Shin, H
Davicioni, E
Feng, F Y
Article History
Received: 21 July 2016
Revised: 14 September 2016
Accepted: 12 October 2016
First Online: 24 January 2017
Competing interests
: PLN has consulted for Medivation, GenomeDx and Ferring. FYF has consulted for Medivation and GenomeDx. NEM has received personal fees from Via Oncology. VC, BP-A, TK, HS and ED are all employees of GenomeDx Biosciences. The remaining authors declare no conflicts of interest.